Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Labenz

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
United European Gastroenterology Journal|April 16, 2025
Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening MethodHenrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2023
Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35Julia Ortner, Reyn Joris Van Ewijk, Louis Velthuis, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Adding Estimates of Central Venous Pressure Boosts the Performance of Non-Invasive Assessment of the Portosystemic Gradient Prior to TIPS ImplantationFabian Stoehr, Maximilian Moos, Lukas Müller, et al.
JHEP Reports : Innovation in Hepatology|July 22, 2024
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre studySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 19, 2024
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven, et al.
United European Gastroenterology Journal|November 28, 2022
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndromeSophia Heinrich, Thomas Austgen, Darko Castven, et al.
JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise programYvonne Huber, Daniel Pfirrmann, Ines Gebhardt, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
United European Gastroenterology Journal|April 16, 2025
Minimal Hepatic Encephalopathy in Cirrhotic Patients: A New Simple and Fast Digital Screening MethodHenrike Dobbermann, Raffael Schlüter, Yevgeniy Lyubchenko, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2023
Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35Julia Ortner, Reyn Joris Van Ewijk, Louis Velthuis, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Adding Estimates of Central Venous Pressure Boosts the Performance of Non-Invasive Assessment of the Portosystemic Gradient Prior to TIPS ImplantationFabian Stoehr, Maximilian Moos, Lukas Müller, et al.
JHEP Reports : Innovation in Hepatology|July 22, 2024
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre studySimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 19, 2024
Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2Eva Maria Schleicher, Simon Johannes Gairing, Darko Castven, et al.
United European Gastroenterology Journal|November 28, 2022
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndromeSophia Heinrich, Thomas Austgen, Darko Castven, et al.
JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
Alimentary Pharmacology & Therapeutics|July 26, 2019
Improvement of non-invasive markers of NAFLD from an individualised, web-based exercise programYvonne Huber, Daniel Pfirrmann, Ines Gebhardt, et al.
Gastro Hep Advances|April 9, 2026
Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult PopulationLaurens A van Kleef, Maurice Michel, Mesut Savas, et al.
Pageof 15